<?xml version="1.0"?>

<document>
	<title>Pseudomonas aeruginosa infection: pathogenesis and therapy.</title>

	<author>Pennington-J-E.</author>

	<source>Compr-Ther. 1979 May. 5(5). P 14-22.</source>

	<abstract>Infection with the gram-negative bacillus, Pseudomonas aeruginosa, is
   less common than infections with Escherichia coli, Klebsiella
   pneumoniae, and Proteus sp; however, the mortality associated with
   pseudomonas sepsis exceeds that found with the more commonly isolated
   gram-negative bacilli by a considerable margin.  While explanations
   exist for this increased virulence of pseudomonas, including
   secretions of toxic exoproducts and a high degree of antibiotic
   resistance, the precise reasons for such unfavorable clinical
   experience with this organism are uncertain.  The current interest in
   pseudomonas infection is partly due to the ever-increasing numbers of
   immunosuppressed and granulocytopenic patients seen in clinical
   practice.  The organism, pathogenesis, clinical presentations (burn
   patients, nosocomial infections, immunosuppressed patients, cystic
   fibrosis), and therapy are discussed.</abstract>

	<majorsubject>PSEUDOMONAS-INFECTIONS: th</majorsubject>

	<minorsubject>BACTERIAL-VACCINES: tu</minorsubject>
	<minorsubject>BURNS: co</minorsubject>
	<minorsubject>CARBENICILLIN: tu</minorsubject>
	<minorsubject>CROSS-INFECTION: et</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: co</minorsubject>
	<minorsubject>GENTAMICINS: tu</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>IMMUNOSUPPRESSION: ae</minorsubject>
	<minorsubject>PSEUDOMONAS-AERUGINOSA: im</minorsubject>
	<minorsubject>PSEUDOMONAS-INFECTIONS: di, et</minorsubject>
	<minorsubject>TICARCILLIN: tu</minorsubject>
	<minorsubject>TOBRAMYCIN: tu</minorsubject>
	<minorsubject>WOUND-INFECTION: et</minorsubject>

	<reference>001   REYNOLDS HY           ANN INTERN MED                  82   819 975</reference>
	<reference>002   LIU PV                J INFECT DIS SUPPL             130    94 974</reference>
	<reference>003   YOUNG LS              J INFECT DIS SUPPL             130   111 974</reference>
	<reference>004   TAPPER ML             J INFECT DIS SUPPL             130    14 974</reference>
	<reference>005   STEVENS RM            ARCH INTERN MED                134   106 974</reference>
	<reference>006   IANNINI PB            JAMA                           230   558 974</reference>
	<reference>007   PENNINGTON JE         AM J MED                        55   155 973</reference>
	<reference>008   SCHIMPFF SC           ANN INTERN MED                  77   707 972</reference>
	<reference>009   PENNINGTON JE         J INFECT DIS                   131   158 975</reference>
	<reference>010   NOONE P               BR MED J                         1   477 974</reference>
	<reference>011   ANDRIOLE VT           J INFECT DIS                   129   124 974</reference>
	<reference>012   PARRY MF              AM J MED                        64   961 978</reference>
	<reference>013   KLASTERSKY J          CHEST                           61   117 972</reference>
	<reference>014   FEELEY TW             N ENGL J MED                   293   471 975</reference>
	<reference>015   PENNINGTON JE         J INFECT DIS SUPPL             130   159 974</reference>

	<citation>1   HEIMBACH DM           REV INFECT DIS                   6  S744 984</citation>
	<citation>2   KNOLLE P              BURNS                           11    54 984</citation>
	<citation>3   HOLDER IA             CAN J MICROBIOL                 31   393 985</citation>
	<citation>4   SCHENTAG JJ           AM J MED                        78    34 985</citation>

</document>
